154 related articles for article (PubMed ID: 2737530)
1. Methotrexate-resistant mechanisms in human choriocarcinoma cells.
Sakai K; Wake N; Fujino T; Yasuda T; Kato H; Fujimoto S; Fujinaga K
Gynecol Oncol; 1989 Jul; 34(1):7-11. PubMed ID: 2737530
[TBL] [Abstract][Full Text] [Related]
2. [MTX resistant mechanisms in human choriocarcinoma cells].
Sakai K; Fujino T; Hoshi S; Shinkai N; Hashimoto M; Yasuda T; Kato H; Yamada H; Wake N; Ichinoe K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):807-14. PubMed ID: 3474305
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].
Sakai K
Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466
[TBL] [Abstract][Full Text] [Related]
4. Dihydrofolate reductase transcript level is not suitable for methotrexate-resistance prediction in choriocarcinoma cell line.
Han B; Xiang Y; Wang Y; Wang Z; Zhang H; Huang S
Int J Gynecol Cancer; 2010 Oct; 20(7):1259-63. PubMed ID: 21495249
[TBL] [Abstract][Full Text] [Related]
5. Development of methotrexate-resistant human choriocarcinoma cells in culture.
Sekiya S; Kaiho T; Takamizawa H
Gynecol Oncol; 1985 May; 21(1):46-53. PubMed ID: 4039287
[TBL] [Abstract][Full Text] [Related]
6. Effect of methotrexate on the growth and human chorionic gonadotropin secretion of human choriocarcinoma cell lines in vitro.
Sekiya S; Kaiho T; Shirotake S; Iwasawa H; Takeda B; Takamizawa H
Am J Obstet Gynecol; 1983 May; 146(1):57-64. PubMed ID: 6682628
[TBL] [Abstract][Full Text] [Related]
7. [Characterization of two choliocarcinoma cell lines and their sensitivity to MTX].
Kaiho T; Sekiya S; Inaba N; Shirotake S; Katoh T; Kobayashi O; Ishige H; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan; 35(1):1-9. PubMed ID: 6681829
[TBL] [Abstract][Full Text] [Related]
8. Selective overproduction of human dihydrofolate reductase in a methotrexate-resistant human-mouse somatic cell hybrid.
Sastry KJ; Chan TS; Rodriguez LV
Biochem Biophys Res Commun; 1985 Oct; 132(2):795-803. PubMed ID: 4062946
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of methotrexate-sensitivity of choriocarcinoma cells in culture.
Inoue T; Nagura E; Toyoda T; Ishizuka T; Gotoh S; Kawashima K; Tomoda Y; Nagai Y
Jpn J Cancer Res; 1988 Mar; 79(3):400-5. PubMed ID: 2836349
[TBL] [Abstract][Full Text] [Related]
10. [Isolation and properties of methotrexate-resistant choriocarcinoma cells in vitro].
Kaiho T; Sekiya S; Shirotake S; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2517-24. PubMed ID: 6542932
[TBL] [Abstract][Full Text] [Related]
11. A new myeloblastic leukemia cell line with double minute chromosomes. Induction of methotrexate resistance and dihydrofolate reductase gene amplification.
Saito H; Kishi K; Narita M; Furukawa T; Nagura E; Maekawa T; Abe T; Shibata A
Leuk Res; 1992; 16(3):217-26. PubMed ID: 1560671
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the propensity for gene amplification between near-tetraploid and near-diploid V79 clones resistant to 150 nM methotrexate.
Hashimoto MW; Nikaido O; Kobayashi N; Chang CC; Trosko JE; Mori T
Carcinogenesis; 1996 Mar; 17(3):389-94. PubMed ID: 8631121
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of resistance to antifolates, a review.
Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate-induced resistance to dactinomycin in choriocarcinoma.
Goto S; Okayama Y; Fan C; Ueda S; Saito M; Furuhashi Y; Ishizuka T; Tomoda Y
Cancer; 1988 Sep; 62(5):873-7. PubMed ID: 3409169
[TBL] [Abstract][Full Text] [Related]
15. Molecular structure and evolution of double-minute chromosomes in methotrexate-resistant cultured mouse cells.
Hahn PJ; Nevaldine B; Longo JA
Mol Cell Biol; 1992 Jul; 12(7):2911-8. PubMed ID: 1620104
[TBL] [Abstract][Full Text] [Related]
16. Lectin galactoside-binding soluble 3 binding protein mediates methotrexate resistance in choriocarcinoma cell lines.
Chen X; Xue Y; Wang L; Weng Y; Li S; Lü W; Xie X; Cheng X
Bioengineered; 2022 Feb; 13(2):2076-2086. PubMed ID: 35038949
[TBL] [Abstract][Full Text] [Related]
17. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug.
Srimatkandada S; Schweitzer BI; Moroson BA; Dube S; Bertino JR
J Biol Chem; 1989 Feb; 264(6):3524-8. PubMed ID: 2914962
[TBL] [Abstract][Full Text] [Related]
18. [Methotrexate and its drug resistance].
Nagura E
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2882-7. PubMed ID: 3178237
[TBL] [Abstract][Full Text] [Related]
19. Differential alterations of dihydrofolate reductase gene in human leukemia cell lines made resistant to various folate analogues.
Miyachi H; Takemura Y; Kobayashi H; Ando K; Ando Y
Jpn J Cancer Res; 1993 Jan; 84(1):9-12. PubMed ID: 8449831
[TBL] [Abstract][Full Text] [Related]
20. Chromosome breakpoints near CpG islands in double minutes.
Foureman P; Winfield JA; Hahn PJ
Gene; 1998 Sep; 218(1-2):121-8. PubMed ID: 9751810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
